Ownership of supply chain data is becoming contentious
Pharmaceutical Commerce - September 2018
Known as the “King of Cold Chain,” Bishara looks both back and ahead at progress in upgrading pharma’s logistics practices
Pharma supply chain managers now have options for dealing with cryogenic to room-temperature ranges
More biologic-based therapies translates into more cold chain activity. As yet, new cellular and genetic therapies are a minute part of the overall market.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Continuous Vendor Oversight Is Key to Healthcare Data Security
2
Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch
3
One Connection, Endless Impact: Improving Patient Medication Access
4
Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands
5
